Log In
Print this Print this

Lunaphen (4-PB)

  Manage Alerts
Collapse Summary General Information
Company Lunamed AG
DescriptionProlonged low-dose slow-release sodium-4-phenylbutyrate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today